Edwards Lifesciences Corp

Pure Financial Advisors, LLC EW

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/10/2026

Shares

2,588

Value ($000)

207

Weight

0.0%

2019 Q4 - 2026 Q1 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/10/2026	207	0.0%	2,588	3/31/2026
2023 Q3	10/10/2023	212	0.0%	3,061	9/30/2023
2023 Q2	7/10/2023	255	0.0%	2,704	6/30/2023
2023 Q1	4/11/2023	1,474	0.1%	17,815	3/31/2023
2022 Q4	1/9/2023	1,322	0.1%	17,715	12/31/2022
2022 Q3	10/6/2022	1,466	0.1%	17,743	9/30/2022
2022 Q2	7/8/2022	1,685	0.1%	17,723	6/30/2022
2022 Q1	4/12/2022	1,864	0.1%	15,834	3/31/2022
2021 Q4	1/12/2022	2,054	0.1%	15,852	12/31/2021
2021 Q3	10/7/2021	1,797	0.1%	15,875	9/30/2021
2021 Q2	7/9/2021	1,638	0.1%	15,816	6/30/2021
2021 Q1	4/9/2021	1,366	0.1%	16,326	3/31/2021
2020 Q4	1/12/2021	1,492	0.2%	16,356	12/31/2020
2020 Q3	10/7/2020	1,303	0.2%	16,326	9/30/2020
2020 Q2	7/8/2020	1,128	0.2%	16,326	6/30/2020
2020 Q1	4/7/2020	1,011	0.2%	5,361	3/31/2020
2019 Q4	1/9/2020	1,251	0.2%	5,361	12/31/2019